Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Beyond Air, Inc. (XAIR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/11/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/28/2023 D Form D - Notice of Exempt Offering of Securities:
03/24/2023 8-K Other Events  Interactive Data
03/23/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Beyond Air Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer"
03/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2023 8-K Quarterly results
01/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/14/2022 8-K Quarterly results
Docs: "BEYOND AIR, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2022 March 31, 2022 ASSETS Current assets Cash and cash equivalents $ 29,829 $ 80,242 Marketable Securities 32,617 - Restricted cash 10,106 9,988 Inventory, net 711 350 Grant receivable 235 322 Other current assets and prepaid expenses 1,581 2,044 Total current assets 75,078 92,945 Licensed right to use technology 1,734 1,837 Right-of-use lease assets 2,265 2,216 Property and equipment, net 2,757 1,995 Other assets 205 207 TOTAL ASSETS $ 82,039 $ 99,199 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable $ 2,006 $ 1,129 Accrued expenses 8,934 8,374 Operating lease liability 348 281 Loan payable, current portion 310 927 Total current liabilities 11,598 10,712 Long-term liabilities Ope...",
"GARDEN CITY, NY and HAMILTON, BERMUDA, November 10, 2022 –"
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/20/2022 8-K Quarterly results
10/07/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
09/22/2022 CT ORDER Form CT ORDER - Confidential treatment order:
08/23/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Beyond Air® Affiliate Beyond Cancer ™ Doses Initial Patient in First-in-Human Phase 1study of Ultra- High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center"
08/15/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/05/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/28/2022 10-K Annual Report for the period ended March 31, 2022
03/04/2022 8-K Quarterly results
02/18/2022 5 Carey Robert (Director) has filed a Form 5 on Beyond Air, Inc.
02/14/2022 8-K Quarterly results
Docs: "BEYOND AIR, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS December 31, 2021 March 31, 2021 ASSETS Current assets Cash and cash equivalents $ 83,468 $ 34,631 Restricted cash 9,239 637 Grant receivable 661 425 Other current assets and prepaid expenses 1,317 1,530 Total current assets 94,684 37,223 Licensed right to use technology 346 375 Right-of-use lease assets 2,299 1,861 Property and equipment, net 1,772 929 Other assets 209 138 TOTAL ASSETS $ 99,311 $ 40,525 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable $ 1,611 $ 1,325 Accrued expenses 4,328 1,805 Operating lease liability 239 113 Loan payable - 557 Total current liabilities 6,178 3,800 Long-term liabilities Operating lease liability 2,162 1,789 Long-term debt, net 200 4,472 Total liabilities 8,..."
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 10-Q Quarterly Report for the period ended December 31, 2021
02/08/2022 SC 13G/A Mosseri Marlio Charles reports a 7.8% stake in Beyond Air, Inc.
02/04/2022 8-K Quarterly results
02/04/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/02/2022 EFFECT Form EFFECT - Notice of Effectiveness:
01/24/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
01/21/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/21/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/10/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy